Category: Opinions+
-
Opinion: STAT+: Why this cardiologist is cautious about the Apple Watch’s blood pressure feature
Opinion: STAT+: Why this cardiologist is cautious about the Apple Watch’s blood pressure feature Welcome to The Workup, a First Opinion column from Vishal Khetpal. As a physician in the age of wearables, glancing at a patient’s wrist has become a natural, unspoken part of the physical exam. In most cases, finding an Apple Watch doesn’t…
-
Opinion: STAT+: The World Health Assembly’s giant leap on rare diseases
Opinion: STAT+: The World Health Assembly’s giant leap on rare diseases On May 24, the World Health Assembly, the governing body of the WHO, ratified landmark legislation that, if implemented fully, will change the future for people living with rare diseases. It calls for concrete action plans that will have far-reaching impacts across health care…
-
Opinion: STAT+: Bristol Myers Squibb CEO: Pharmaceutical innovation requires bold yet predictable U.S. policy
Opinion: STAT+: Bristol Myers Squibb CEO: Pharmaceutical innovation requires bold yet predictable U.S. policy Having grown up in rural Arkansas, I have an acute awareness of the challenges many in our country face when it comes to health care. Quality care wasn’t always accessible, and the decision of whether to pay medical or utility bills…
-
Opinion: STAT+: Peter Marks’ ouster is an ominous sign for biotech — and for public health
Opinion: STAT+: Peter Marks’ ouster is an ominous sign for biotech — and for public health Welcome to Lab Dish, a new First Opinion column on regenerative medicine from Paul Knoepfler. There are certain leaders who quietly make complex organizations operate well including in the toughest of times — leaders like Peter Marks, director of…